NCI 12H05 (Protocol 8309): Phase I/II Investigation of Temsirolimus Plus Lenalidomide in Relapsed Non-Hodgkin Lymphomas: Subproject for Institution # SP0012448

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/30/129/22/16

Funding

  • The University of Chicago (5-27050 / HHSN261201100071C)
  • National Cancer Institute (5-27050 / HHSN261201100071C)